Category: Press Release

October 20, 2026

Oct 19, 2026, 07:01 ET - Clearance enables initiation of SHIELD-AL, a pivotal study in newly diagnosed patients with lambda…

September 8, 2026

August 12, 2026 NAPLES, Fla., August 12, 2026 — Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to…